TransSerum? FQ Fetal Bovine Serum
胎牛血清 FQ
| 目錄號(hào) | 規(guī)格 | 單價(jià) |
|---|---|---|
| FS301-02 | 500 ml | 4800 |
產(chǎn)品詳情介紹
本產(chǎn)品以健康胎牛血液為原料加工而成，經(jīng)3次0.1 μm微孔濾膜過濾，無支原體污染，不含BVDV、BPV等牛源病毒，內(nèi)毒素水平極低。培養(yǎng)細(xì)胞種類多，細(xì)胞生長(zhǎng)速度快，狀態(tài)好，適用于間充質(zhì)干細(xì)胞的培養(yǎng)。培養(yǎng)的細(xì)胞適用于多種下游實(shí)驗(yàn)。
【廣譜通用型】“夠用不貴”的性價(jià)比典范，為多種常見傳代細(xì)胞系提供穩(wěn)定可靠的支持。
應(yīng)用范圍：適用于間充質(zhì)干細(xì)胞及常見傳代細(xì)胞如A549、HeLa、Vero、MDCK等多種細(xì)胞的培養(yǎng)。
TransSerum? FQ Fetal Bovine Serum成功培養(yǎng)的細(xì)胞
穩(wěn)定性好
病毒檢測(cè)
支原體檢測(cè)
間充質(zhì)干細(xì)胞培養(yǎng)圖
普通細(xì)胞培養(yǎng)圖 (部分結(jié)果)
血清介紹視頻
1.Shen Y, Wang J, Li Y, et al. Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2[J]. Cell Discovery, 2022.(IF 38.08)
2.Xu Y, Chen J, Liu Y, et al. The macrophage-derived motor protein KIF13B enhances MERTK-mediated efferocytosis and prevents atherosclerosis in mice[J]. European Heart Journal, 2025,(IF 35.60)
3.Wang A, Tian Y, Liu H, et al. Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein[J]. Emerging Microbes & Infections, 2022,(IF 19.57)
4.Xiang H, Yang J, Cao X, et al. Flexible and highly sensitive triboelectric nanogenerator with magnetic nanocomposites for cultural heritage conservation and human motion monitoring[J]. Nano Energy, 2022.(IF 19.06)
5.Wang Z, Chen Z, Zhang Z, et al. Multifunctional high boron content MOFs nano-co-crystals for precise boron neutron capture therapy for brain glioma in situ[J]. Nano Today, 2022.(IF 18.96)
6.Chen K, Zhou R, Liang H, et al. Reversing the pathological microenvironment by radiocatalytic sensitizer for local orthotopic osteosarcoma radiotherapy enhancement[J]. Nano Today, 2023.(IF 17.40)
7.Chen K, Liu S, Lv L, et al. Well-established immunotherapy with R837-loaded boron neutron capture-shocked tumor cells[J]. Nano Today, 2023.(IF 17.40)
8.Qin P P, Chen P R, Tan L, et al. Programming ADAR-recruiting hairpin RNA sensor to detect endogenous molecules[J]. Nucleic Acids Research, 2025.(IF 16.70)
9.Chen P R, Qin P P, Wang Y N, et al. De novo design of hypercompact transcript degraders by engineering substrate-specific toxins and Cas6-CBS system[J]. Nature Communications, 2025,(IF 15.70)
10.Hou P, Zhu H, Chu F, et al. Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-?B[J]. Nature Communications, 2025.(IF 15.70)
11.Liang H, Chen K, Xie J, et al. A Bone‐Penetrating Precise Controllable Drug Release System Enables Localized Treatment of Osteoporotic Fracture Prevention via Modulating Osteoblast‐Osteoclast Communication[J]. Small, 2023.(IF 15.15)
12.Ma P Q, Huang F W, Xie Y Q, et al. Universal DNA-Based Sensing Toolbox for Programming Cell Functions[J]. Journal of the American Chemical Society, 2023.(IF 15.00)
13.Liu H, Fan H, He P, et al. Prohibitin 1 regulates mtDNA release and downstream inflammatory responses[J]. The EMBO Journal, 2022.(IF 14.01)
14.Hou P, Wang X, Wang H, et al. The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication[J]. Autophagy, 2022.(IF 13.39)
15.Wang Y, Lv L, Liang H, et al. Clot structure-based physical-matching design of platelet cloaking nano-delivery system facilitates specific arteriovenous thrombolysis[J]. Chemical Engineering Journal, 2022.(IF 13.00)
16.Liang W, Chen K, Lv L, et al. Radial extracorporeal shock wave responsive precise nanoplatform for effective osteoporosis sequential treatment[J]. Chemical Engineering Journal, 2021.(IF 10.65)
17.Sun Y, Wang Y, Liu C, et al. Targeted degradation of oncogenic BCR-ABL by silencing the gene of NEDD8 E3 ligase RAPSYN[J]. Journal of Nanobiotechnology, 2024.(IF 10.20)
